Impact of UGT1A4, UGT2B7, and UGT2B15 pharmacogenetics on tamoxifen (TAM) metabolism.

被引：0
|
作者：
Lim, Joanne Siok-Liu
Ganchev, Boian
Singh, Onkar
Muerdter, Thomas E.
Yap, Yoon Sim
Ng, Raymond C. H.
Wong, Nan Soon
Schwab, Matthias
Chowbay, Balram
机构：
[1] Natl Canc Ctr, Div Med Sci, Lab Clin Pharmacol, Singapore, Singapore
[2] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[3] Univ Tubingen, Stuttgart, Germany
[4] Natl Canc Ctr, Div Med Sci, Singapore, Singapore
[5] Natl Canc Ctr Singapore, Singapore, Singapore
[6] Natl Canc Ctr, Singapore, Singapore
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2588
引用
收藏
页数：1
相关论文
共 50 条
  • [31] UGT2B7 is not expressed in normal breast
    Sun, Chang
    Di Rienzo, Anna
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (01) : 225 - 226
  • [32] Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTS):: S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9
    Court, MH
    Duan, SX
    Guillemette, C
    Journault, K
    Krishnaswamy, S
    Von Moltke, LL
    Greenblatt, DJ
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (11) : 1257 - 1265
  • [33] Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family:: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y)
    Lampe, JW
    Bigler, J
    Bush, AC
    Potter, JD
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2000, 9 (03) : 329 - 333
  • [34] Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion
    He, Xi
    Hesse, Leah M.
    Hazarika, Suwagmani
    Masse, Gina
    Harmatz, Jerold S.
    Greenblatt, David J.
    Court, Michael H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (05) : 721 - 730
  • [35] UDP-glucuronosyltransferase 2B15 (UGT2B15) Is the Major Enzyme Responsible for Sipoglitazar Glucuronidation in Humans: Retrospective Identification of the UGT Isoform by In Vitro Analysis and the Effect of UGT2B15*2 Mutation
    Nishihara, Mitsuhiro
    Hiura, Yuto
    Kawaguchi, Naohiro
    Takahashi, Junzo
    Asahi, Satoru
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (06) : 475 - 484
  • [36] Human Hepatic UGT2B15 Developmental Expression
    Divakaran, Karthika
    Hines, Ronald N.
    McCarver, D. Gail
    TOXICOLOGICAL SCIENCES, 2014, 141 (01) : 292 - 299
  • [37] UGT2B7 is not expressed in normal breast
    Chang Sun
    Anna Di Rienzo
    Breast Cancer Research and Treatment, 2009, 117
  • [38] UGT2B7 requires phosphorylation for activity
    Mitra, PS
    Basu, NK
    Owens, IS
    FASEB JOURNAL, 2004, 18 (08): : C73 - C73
  • [39] Glucuronidation of estrone and 16α-hydroxyestrone by human UGT enzymes: The key roles of UGT1A10 and UGT2B7
    Kallionpaa, Roope A.
    Jarvinen, Erkka
    Finel, Moshe
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 154 : 104 - 111
  • [40] Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells
    Wijayakumara, Dhilushi D.
    Mackenzie, Peter I.
    McKinnon, Ross A.
    Hu, Dong Gui
    Meech, Robyn
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (03): : 386 - 397
12345